{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:36:18Z","timestamp":1785234978684,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,1,30]],"date-time":"2007-01-30T00:00:00Z","timestamp":1170115200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/sj.bjc.6603570","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T18:32:00Z","timestamp":1170441120000},"page":"551-558","source":"Crossref","is-referenced-by-count":51,"title":["A phase I\/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study"],"prefix":"10.1038","volume":"96","author":[{"given":"R","family":"Glynne-Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T S","family":"Maughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H M","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Sebag-Montefiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"BF6603570_CR1","unstructured":"Becerra CR, Cho LC, Gregorcyk S, Simmang C, Frenkel EP, Verma UN (2005) A phase I study with irinotecan, capecitabine and radiation therapy for patients with locally advanced or metastatic rectal cancer. Proc Am Soc Clin Oncol GI Symposium (abstract 212)"},{"key":"BF6603570_CR2","first-page":"58","volume":"1","author":"KF Birbeck","year":"1999","unstructured":"Birbeck KF, Quirke P (1999) Reporting protocols in colorectal cancer. CPD Bull Cell Pathol 1: 58\u201364","journal-title":"CPD Bull Cell Pathol"},{"key":"BF6603570_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ijc.2910530122","volume":"53","author":"RE Boscia","year":"1993","unstructured":"Boscia RE, Korbut T, Holden SA, Ara G, Teicher BA (1993) Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum (II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo. Int J Cancer 53: 118\u2013123","journal-title":"Int J Cancer"},{"key":"BF6603570_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2003.09.032","volume":"40","author":"JF Bosset","year":"2004","unstructured":"Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, Bardet E, Pierart M, Briffaux A (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40: 219\u2013224","journal-title":"Eur J Cancer"},{"key":"BF6603570_CR5","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","volume":"23","author":"JF Bosset","year":"2005","unstructured":"Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L (2005a) Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results \u2013 EORTC 22921. J Clin Oncol 23: 5620\u20135627","journal-title":"J Clin Oncol"},{"key":"BF6603570_CR6","first-page":"16S","volume":"23","author":"JF Bosset","year":"2005","unstructured":"Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier A, Collette L (2005b) Preoperative radiation (Preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. Proc Am Soc Clin Oncol 23: 16S (abstract 3505)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR7","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/0360-3016(82)90451-5","volume":"8","author":"JE Byfield","year":"1982","unstructured":"Byfield JE, Colaboro-Jones P, Klisak I, Kulhanian F (1982) Pharmacological requirements for obtaining sensitisation of human tumour cells in vitro to combined 5-flourouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 8: 1923\u20131933","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","volume":"284","author":"C Camm\u00e0","year":"2000","unstructured":"Camm\u00e0 C, Giunta M, Fiorica F, Pagliaro L, Crax\u00ec A, Cottone M (2000) Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284: 1008\u20131015","journal-title":"JAMA"},{"key":"BF6603570_CR9","first-page":"39","volume":"13","author":"AY Chen","year":"1999","unstructured":"Chen AY, Choy H, Rothenberg ML (1999) DNA topoisomerase I-targeting drugs as radiation sensitizers. Oncology 13: 39\u201346","journal-title":"Oncology"},{"key":"BF6603570_CR10","doi-asserted-by":"crossref","unstructured":"Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358: 1291\u20131304","DOI":"10.1016\/S0140-6736(01)06409-1"},{"key":"BF6603570_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","volume":"355","author":"JY Douillard","year":"2000","unstructured":"Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041\u20131047","journal-title":"Lancet"},{"key":"BF6603570_CR12","first-page":"335","volume":"181","author":"WE Enker","year":"1995","unstructured":"Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181: 335\u2013346","journal-title":"J Am Coll Surg"},{"key":"BF6603570_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/09553009214551601","volume":"61","author":"SJ Falk","year":"1992","unstructured":"Falk SJ, Smith PJ (1992) DNA damaging and cell cycle effects of topoisomerase I poison camptothecin in irradiated human cells. Int J Radiation Biol 61: 749\u2013757","journal-title":"Int J Radiation Biol"},{"key":"BF6603570_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(01)01479-1","volume":"50","author":"GJ Frykholm","year":"2001","unstructured":"Frykholm GJ, Pahlman L, Glimelius B (2001) Combined chemo- and radiotherapy vs radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 50: 427\u2013434","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR15","first-page":"16S","volume":"23","author":"J Gerard","year":"2005","unstructured":"Gerard J, Bonnetain F, Conroy T, Chapet O, Bouche O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Bedenne L (2005) Preoperative (preop) radiotherapy (RT) + 5 FU\/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. Proc Am Soc Clin Oncol 23: 16S (abstract 3504)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR16","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1200\/JCO.2006.06.1143","volume":"24","author":"SW Gollins","year":"2006","unstructured":"Gollins SW, Myint S, Levine E, Bishop J, Haylock B, Susnerwala S, Saunders M, Biswas A (2006) Radiotherapy plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer: A phase I\/II study. Proc Am Soc Clin Oncol 24: 18S (abstract 13519)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR17","first-page":"16S","volume":"23","author":"SW Gollins","year":"2005","unstructured":"Gollins SW, Myint S, Levine E, Morris J, Haylock B, Susnerwala S, Saunders M, Biswas A (2005) Phase I study of radiotherapy (RT) plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer. Proc Am Soc Clin Oncol 23: 16S (abstract 3565)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1259\/bjr\/86650067","volume":"78","author":"A Hartley","year":"2005","unstructured":"Hartley A, Ho KF, McConkey C, Geh JI (2005) Pathological complete response following preoperative chemoradiotherapy in rectal cancer analysis of phase II\/III trials. Br J Radiol 78: 934\u2013938","journal-title":"Br J Radiol"},{"key":"BF6603570_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","volume":"133","author":"RJ Heald","year":"1998","unstructured":"Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978\u20131997. Arch Surg 133: 894\u2013899","journal-title":"Arch Surg"},{"key":"BF6603570_CR20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1200\/JCO.2005.04.171","volume":"23","author":"R-D Hofheinz","year":"2005","unstructured":"Hofheinz R-D, Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Muldner A, Hehlmann R, Post S, Hochhaus A, Willeke F (2005) Phase I Trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23: 1350\u20131357","journal-title":"J Clin Oncol"},{"key":"BF6603570_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, for the Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638\u2013646","journal-title":"N Engl J Med"},{"key":"BF6603570_CR22","unstructured":"Kennedy AS, Kwok Y, Batko-Yovino S, Van Echo DA (2004) A phase I study of preoperative capecitabine, irinotecan concurrent with radiation therapy for resectable rectal cancer. Proc Am Soc Clin Oncol GI Symposium (abstract 268)"},{"issue":"2 Suppl","key":"BF6603570_CR23","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1016\/j.ijrobp.2005.07.284","volume":"63","author":"C Kim","year":"2005","unstructured":"Kim C, Anne PR, Mitchell E, Pequignot E, Palazzo J, Goldstein S, Isenberg G, Curran Jr W (2005) Impact of pretreatment size and lymph nodes on pathological complete response and survival in a prospective trial of chemoradiation. Int J Radiat Oncol Biol Phys 63 (2 Suppl): S164 (abstract 1034)","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0360-3016(99)00062-0","volume":"44","author":"AV Kirichenko","year":"1999","unstructured":"Kirichenko AV, Rich TA (1999) Radiation enhancement by a minor camptothesin. The effect of fractionation and timing of administration. Int J Radiat Oncol Biol Phys 44: 659\u2013664","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR25","first-page":"1929","volume":"57","author":"AV Kirichenko","year":"1997","unstructured":"Kirichenko AV, Rich TA, Newman RA, Travis EL (1997) Potentiation of murine MCa \u2013 4 carcinoma radioresponse by 9-amino-20s camptothecin. Cancer Res 57: 1929\u20131933","journal-title":"Cancer Res"},{"key":"BF6603570_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.bjc.6602492","volume":"92","author":"G Klautke","year":"2005","unstructured":"Klautke G, Feyerhead P, Ludwig K, Prall F, Foitzik T, Fietkau R (2005) Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92: 1215\u20131220","journal-title":"Br J Cancer"},{"key":"BF6603570_CR27","first-page":"14S","volume":"22","author":"G Klautke","year":"2004","unstructured":"Klautke G, Foitzik T, Ludwig K, Klar EJM, Fietkau R (2004) Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): a phase I\/II study. Proc Am Soc Clin Oncol 22: 14S (abstract 3693)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/sj.bjc.6603053","volume":"94","author":"G Klautke","year":"2006","unstructured":"Klautke G, Kuchenmeister U, Foitzik T, Ludwig K, Prall F, Klar E, Fietkau R (2006a) Concurrent chemoradiation with capectitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I\/II study. Br J Cancer 94: 976\u2013981","journal-title":"Br J Cancer"},{"key":"BF6603570_CR29","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1200\/JCO.2006.06.1143","volume":"24","author":"G Klautke","year":"2006","unstructured":"Klautke G, Ludwig K, Klar E, Freund M, Fietkau R (2006b) Toxicity and efficacy of four schedules of intensified neoadjuvant chemoradiotherapy (RCT) with irinotecan and 5-Fu or capectitabine in patients with locally advanced rectal cancer. Proc Am Soc Clin Oncol 24: 18S (abstract 13550)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR30","unstructured":"Levine EL, Gollins S, Susnerwala S, Haylock B, Saunders M, Myint S, Biswas A (2003) Phase I\/II study of irinotecan (CPT11) 5-flourouracil and concurrent radiotherapy in the treatment of T3\u2013T4 locally advanced inoperable rectal cancer. Proc Am Soc Clin Oncol Onc 22 (abstract 1384) p 345"},{"key":"BF6603570_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijrobp.2005.03.003","volume":"63","author":"S Mawdsley","year":"2005","unstructured":"Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3\u2013T4 rectal cancer predict for 3 year disease-free survival. Int J Radiat Oncol Biol Phys 63: 745\u2013752","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0360-3016(02)03863-4","volume":"55","author":"VK Mehta","year":"2003","unstructured":"Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G (2003) Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil and weekly CPT-11, followed by surgery for ultrasound staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55: 132\u2013137","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR33","first-page":"131a","volume":"20","author":"EP Mitchell","year":"2001","unstructured":"Mitchell EP, Anne P, Fry R, Ahmed N, Boman B, Edmunston T, Rakinic J, Goldstein S, Rose L, Palazzo J, Cagir B, Kovatich A, Hauck W, Fishel R, Bonanni R, Hoey R, Rose D, Currani W, Jefferson T (2001) Combined modality therapy of locally advanced or recurrent adenocarcinoma of the rectum: report of a phase I trial of chemotherapy (CT) with CPT 11, 5\u2009FU and concomitant irradiation (RT). Proc Am Soc Clin Oncol 20: 131a (abstract 519)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603570_CR34","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1200\/JCO.2006.06.1143","volume":"24","author":"EP Mitchell","year":"2006","unstructured":"Mitchell EP, Anne P, Goldstein S, Isenbergn G, Fitzgerald J, Palazzo J, Hauck W, Lavarino J, Sanson J, Curran W (2006) Combined modality therapy of locally advanced adenocarcinoma of the rectum: update of a phase I trial of preoperative radiation (RT) with concurrent capecitabine (Cap) and irinotecan (Ir). Pro Am Soc Clin Oncol 24: 18S (abstract 13547) 619S","journal-title":"Pro Am Soc Clin Oncol"},{"key":"BF6603570_CR35","unstructured":"Mitchell EP, Anne PR, Fry R, Palazzo J, Hauck W, Fishel R, Goldstein S, Isenberg G, Edmunston T, Curran W (2003) Chemoradiation with CPT 11, 5FU in neoadjuvant treatment of locally advanced or recurrent adenocarcinoma of the rectum: a phase I\/II study update. Proc Am Soc Clin Oncol 22 (abstract 1052) p 262"},{"key":"BF6603570_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","volume":"26","author":"ID Nagtegaal","year":"2002","unstructured":"Nagtegaal ID, Marijnen CA, Kranenbarg EK, Van de Velde CJ, Van Krieken JH, Pathology Review Committee; Cooperative Clinical Investigators (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal cancer: not 1 millimetre but 2 millimetres is the limit. Am J Surg Pathol 26: 350\u2013357","journal-title":"Am J Surg Pathol"},{"key":"BF6603570_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijrobp.2006.04.007","volume":"66","author":"M Navarro","year":"2006","unstructured":"Navarro M, Dotor E, Rivera F, Sanchez-Rovira P, Garcia JL, Vega-Villegas ME, Cervantes A, Garcia JL, Gallen M, Aranda E (2006) A phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-flourouracil, for resectable locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66: 201\u2013205","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603570_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0167-8140(97)01924-5","volume":"43","author":"M Omura","year":"1997","unstructured":"Omura M, Torigoe S, Qubota N (1997) SN38, a metabolite of the camptothecin derivative CPT11 potentiates the cytotoxic effects of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol 43: 197\u2013208","journal-title":"Radiother Oncol"},{"key":"BF6603570_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","volume":"2","author":"P Quirke","year":"1986","unstructured":"Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2: 996\u2013999","journal-title":"Lancet"},{"key":"BF6603570_CR40","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1200\/JCO.2003.02.505","volume":"21","author":"C Rodel","year":"2003","unstructured":"Rodel C, Grabenbauer GG, Papdopoulos T, Hohenberger W, Scholl HJ, Sauer R (2003) Phase I\/II trial of capecitabine, oxaliplatin and radiation for rectal cancer. J Clin Oncol 21: 3098\u20133104","journal-title":"J Clin Oncol"},{"key":"BF6603570_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200009283431302","volume":"343","author":"LB Saltz","year":"2000","unstructured":"Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905\u2013914","journal-title":"N Engl J Med"},{"key":"BF6603570_CR42","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, for the German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731\u20131740","journal-title":"N Engl J Med"},{"key":"BF6603570_CR43","unstructured":"Sebag-Montefiore D, Glynne-Jones R, Mortensen N, Bedi C, Wilson C, Geh I, McDonald A (2005) Pooled analysis of outcome measures including the histopathological R0 resection rate after pre-operative chemoradiation for locally advanced rectal cancer. Colorectal disease 7 (Suppl 1): (abstract O20 p 7)"},{"key":"BF6603570_CR44","doi-asserted-by":"crossref","unstructured":"Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980\u2013987","DOI":"10.1056\/NEJM199704033361402"},{"key":"BF6603570_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1349-7006.1997.tb00369.x","volume":"88","author":"K Tamura","year":"1997","unstructured":"Tamura K, Takada M, Kawase I, Tada T, Kudoh S, Okishio K, Fukuoka MN, Fuliwara Y, Yamakido M (1997) Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. Jpn J Cancer Res 88: 218\u2013223","journal-title":"Jpn J Cancer Res"},{"key":"BF6603570_CR46","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1248\/bpb.19.354","volume":"19","author":"DS Wang","year":"1996","unstructured":"Wang DS, Ueno Y, Oyamada H, Kojima S (1996) Enhancement of the antitumour effect of gamma-ray irradiation in combination with camptothecin against human colorectal adenocarcinoma. Biol Pharm Bull 19: 354\u2013359","journal-title":"Biol Pharm Bull"},{"key":"BF6603570_CR47","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10350-004-0713-x","volume":"47","author":"JM Wheeler","year":"2004","unstructured":"Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortenson NJ (2004) Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 47: 2025\u20132031","journal-title":"Dis Colon Rectum"},{"key":"BF6603570_CR48","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1046\/j.1365-2168.2002.02169_2.x","volume":"89","author":"A Wibe","year":"2002","unstructured":"Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89: 1067","journal-title":"Br J Surg"},{"key":"BF6603570_CR49","first-page":"16S","volume":"23","author":"F Willeke","year":"2005","unstructured":"Willeke F, Tiefenbacher U, Hochhaus A, Wenz F, von Gerstenbergk B, Gnad-Vogt U, Horisberger K, Post S, Hofheinz R (2005) Phase II trial of capecitabine and irinotecan in combination with concurrent radiotherapy for neoadjuvant treatment of locally advanced rectal cancer. Pro Am Soc Clin Oncol 23: 16S (abstract 3589)","journal-title":"Pro Am Soc Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603570","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:25:32Z","timestamp":1684412732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BF6603570"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603570","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}